SCHEMBL6864300

SCHEMBL6864300

CCNc1nc(O)ncc1C#N

nearest known ligand 0.45

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PGK1 P00558 5/20 0.45
▸ AURKA O14965 1/20 0.42
▸ LRRK2 Q5S007 6/20 0.41
▸ SYK P43405 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ MAPK8 P45983 1/20 0.36
▸ EGLN1 Q9GZT9 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766397 0.81 CSNK1A1 (0.51) PGK1LRRK2KDM4EALDH1A1HSD17B10
SCHEMBL11176262 0.74 LRRK2 (0.47) PGK1AURKALRRK2SYK
SCHEMBL20630523 0.70 CSNK1A1 (0.41) AURKASYK
SCHEMBL22688500 0.70 PDGFRB (0.41) AURKALRRK2MAPK8ALDH1A1
SCHEMBL11165586 0.69 PGK1 (0.46) PGK1SMN1; SMN2POLBKDM4EALDH1A1
SCHEMBL22110391 0.69 NPC1 (0.52) PGK1LRRK2KDM4EALDH1A1HPGD
SCHEMBL4765894 0.69 CSNK1A1 (0.50) PGK1AURKALRRK2SYKKDM4E
SCHEMBL2025331 0.68 SMN1; SMN2 (0.45) PGK1AURKALRRK2SMN1; SMN2POLB
SCHEMBL29313773 0.68 CCNA2 (0.46) AURKALRRK2SYKKDM4EALDH1A1
SCHEMBL4768640 0.68 POLB (0.49) PGK1LRRK2SMN1; SMN2POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397351-A1 PYRIMIDINE, TRIAZINE AND PYRAZINE DERIVATIVES AS GLUTAMATE RECEPTORS F. HOFFMANN-LA ROCHE AG (CH) 2004-03-17 — — EP disclosed
WO-2002098864-A1 PYRIMIDINE, TRIAZINE AND PYRAZINE DERIVATIVES AS GLUTAMATE RECEPTORS F. HOFFMANN-LA ROCHE AG (CH) 2002-12-12 — — WO disclosed
Send feedback